Whole-body FXR-deficiency in mouse models of insulin resistance protects mice from diet-induced obesity and glucose intolerance [112–114], independent of hepatic FXR, as hepatic insulin resistance remains unaffected in the absence of FXR [112]. This evidence concerns the gene NR1H4 and obesity disorder.